Literature DB >> 17287994

Placebo analgesia: a PET study.

Hidenori Nemoto1, Yuki Nemoto, Hikaru Toda, Masahiko Mikuni, Hidenao Fukuyama.   

Abstract

Placebo analgesia involves complex mechanisms and sometimes has a marked effect on patients in pain. In this study we examined changes in regional cerebral blood flow (rCBF) under three different conditions (resting, hot, painful) before and after placebo administration using H(2)(15)O and positron emission tomography in ten healthy subjects. In five subjects, placebo administration significantly decreased pain-intensity score (placebo responders), and rCBF in the medial prefrontal cortex (MPFC), posterior parietal cortex (PPC), and inferior parietal lobe (IPL) increased after placebo administration compared with before placebo administration under the painful condition. Furthermore, in the placebo responders, rCBF in the MPFC, PPC and IPL also increased under the resting condition (without sensory stimulation) after placebo administration compared with before placebo administration. However, there was no rCBF change under the rest condition in the placebo nonresponders after placebo administration. These results suggest that placebo analgesia has its effect under the resting condition and MPFC, IPL and PPC may have an important role in placebo analgesia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287994     DOI: 10.1007/s00221-006-0821-z

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   2.064


  17 in total

Review 1.  The cortical representation of pain.

Authors:  R D Treede; D R Kenshalo; R H Gracely; A K Jones
Journal:  Pain       Date:  1999-02       Impact factor: 6.961

2.  Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain.

Authors:  N Tzourio-Mazoyer; B Landeau; D Papathanassiou; F Crivello; O Etard; N Delcroix; B Mazoyer; M Joliot
Journal:  Neuroimage       Date:  2002-01       Impact factor: 6.556

3.  Placebo and opioid analgesia-- imaging a shared neuronal network.

Authors:  Predrag Petrovic; Eija Kalso; Karl Magnus Petersson; Martin Ingvar
Journal:  Science       Date:  2002-02-07       Impact factor: 47.728

4.  Functional neuroanatomy of emotion: a meta-analysis of emotion activation studies in PET and fMRI.

Authors:  K Luan Phan; Tor Wager; Stephan F Taylor; Israel Liberzon
Journal:  Neuroimage       Date:  2002-06       Impact factor: 6.556

Review 5.  Brain mechanisms of pain affect and pain modulation.

Authors:  Pierre Rainville
Journal:  Curr Opin Neurobiol       Date:  2002-04       Impact factor: 6.627

6.  Subcortical and cortical brain activity during the feeling of self-generated emotions.

Authors:  A R Damasio; T J Grabowski; A Bechara; H Damasio; L L Ponto; J Parvizi; R D Hichwa
Journal:  Nat Neurosci       Date:  2000-10       Impact factor: 24.884

7.  Placebo-induced changes in FMRI in the anticipation and experience of pain.

Authors:  Tor D Wager; James K Rilling; Edward E Smith; Alex Sokolik; Kenneth L Casey; Richard J Davidson; Stephen M Kosslyn; Robert M Rose; Jonathan D Cohen
Journal:  Science       Date:  2004-02-20       Impact factor: 47.728

8.  Cerebral responses to a continual tonic pain stimulus measured using positron emission tomography.

Authors:  S W Derbyshire; A K Jones
Journal:  Pain       Date:  1998-05       Impact factor: 6.961

9.  Regional mu opioid receptor regulation of sensory and affective dimensions of pain.

Authors:  J K Zubieta; Y R Smith; J A Bueller; Y Xu; M R Kilbourn; D M Jewett; C R Meyer; R A Koeppe; C S Stohler
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

10.  Fluvoxamine modulates pain sensation and affective processing of pain in human brain.

Authors:  Hidenori Nemoto; Hikaru Toda; Takashi Nakajima; Shin Hosokawa; Yuko Okada; Koujirou Yamamoto; Ryuya Horiuchi; Keigo Endo; Itsuro Ida; Masahiko Mikuni; Fumio Goto
Journal:  Neuroreport       Date:  2003-05-06       Impact factor: 1.837

View more
  9 in total

1.  Activation likelihood estimation meta-analysis of brain correlates of placebo analgesia in human experimental pain.

Authors:  Martina Amanzio; Fabrizio Benedetti; Carlo A Porro; Sara Palermo; Franco Cauda
Journal:  Hum Brain Mapp       Date:  2011-11-29       Impact factor: 5.038

2.  Concurrent functional and structural cortical alterations in migraine.

Authors:  Nasim Maleki; Lino Becerra; Jennifer Brawn; Marcelo Bigal; Rami Burstein; David Borsook
Journal:  Cephalalgia       Date:  2012-05-23       Impact factor: 6.292

3.  Sex similarities and differences in pain-related periaqueductal gray connectivity.

Authors:  Clas Linnman; Jan-Carl Beucke; Karin B Jensen; Randy L Gollub; Jian Kong
Journal:  Pain       Date:  2011-12-06       Impact factor: 6.961

Review 4.  Higher cortical modulation of pain perception in the human brain: Psychological determinant.

Authors:  Andrew Cn Chen
Journal:  Neurosci Bull       Date:  2009-10       Impact factor: 5.203

Review 5.  Brodmann area 10: Collating, integrating and high level processing of nociception and pain.

Authors:  Ke Peng; Sarah C Steele; Lino Becerra; David Borsook
Journal:  Prog Neurobiol       Date:  2017-12-02       Impact factor: 11.685

6.  No evidence that attentional bias towards pain-related words is associated with verbally induced nocebo hyperalgesia: a dot-probe study.

Authors:  Matthew James Coleshill; Louise Sharpe; Ben Colagiuri
Journal:  Pain Rep       Date:  2021-04-06

7.  Somatotopy of placebo analgesia is independent of spatial attention.

Authors:  Claudia Domnick; Jürgen Lorenz; Michael Hauck
Journal:  J Pain Res       Date:  2011-03-24       Impact factor: 3.133

8.  Towards a constructionist approach to emotions: verification of the three-dimensional model of affect with EEG-independent component analysis.

Authors:  Miroslaw Wyczesany; Tomasz S Ligeza
Journal:  Exp Brain Res       Date:  2014-11-26       Impact factor: 1.972

9.  Experimental placebo analgesia changes resting-state alpha oscillations.

Authors:  Nathan T M Huneke; Christopher A Brown; Edward Burford; Alison Watson; Nelson J Trujillo-Barreto; Wael El-Deredy; Anthony K P Jones
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.